Clobetasol Propionate 0.05% Under Occlusion in the Treatment of Alopecia Totalis/Universalis

    July 2003 in “ Journal of the American Academy of Dermatology ”
    Antonella Tosti, Bianca Maria Piraccini, Massimiliano Pazzaglia, Colombina Vincenzi
    Studysummary In this study, clobetasol propionate 0.05% ointment was found to induce hair regrowth in 28.5% of patients with severe alopecia areata under occlusive conditions, though long-term benefit was limited to 17.8%.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on jaad.org →
    Discuss this study in the Community →

    Research cited in this study 4

    1. Current and Potential Agents for the Treatment of Alopecia Areata Current pharmaceutical design · 2001
    2. Efficacy of Topical Sensitizers in the Treatment of Alopecia Areata Journal of the American Academy of Dermatology · 1998
    3. Systemic Steroids With or Without 2% Topical Minoxidil in the Treatment of Alopecia Areata Archives of Dermatology · 1992
    4. Alopecia Totalis: Significant Hair Regrowth with Fluocinolone Acetonide Cream Archives of dermatology · 1963

    Related research 5

    1. Alopecia Areata: Case Report and Review of Pathophysiology and Treatment with JAK Inhibitors Journal of autoimmunity · 2022
    2. The Usefulness and Wellbeing of Tofacitinib in the Treatment of Alopecia Areata Journal of Armed Forces Medical College, Bangladesh · 2022
    3. Transient Efficacy of Tofacitinib in Alopecia Areata Universalis Case Reports in Dermatology · 2016
    4. Alopecia Areata Universalis in a Dog Veterinary dermatology · 2015
    5. PUVA Treatment of Alopecia Areata Totalis and Universalis: A Retrospective Study Australasian journal of dermatology · 2003